Philip James Wealth Mangement, LLC

Position in JNJ — Johnson & Johnson

CIK 2002630 MILTON, GA

Position in JNJ

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$20,801,666

+$233,263 QoQ

Shares Held

81,906

-2.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

2.83%

of 13F equity value

Holder Rank

#727

of 4,676 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Philip James Wealth Mangement, LLC holds $77,068,819 across 8 Drug Manufacturers - General names. JNJ ranks #2 (27.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	173,727	$22,323,919
2	JNJ	Johnson & Johnson This page	81,906	$20,801,666
3	NVO	Novo Nordisk A S	269,741	$12,931,383
4	PFE	Pfizer Inc	443,426	$10,677,698
5	LLY	ELI LILLY & Co	4,241	$5,086,783
6	AMGN	Amgen Inc	8,948	$3,240,249
7	GILD	Gilead Sciences, Inc.	12,976	$1,639,387
8	BIIB	Biogen Inc.	1,702	$367,734

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,801,666	81,906	-2.7%	Shares	Sole	2026-07-27
2026-03-31	$20,568,403	84,145	-1.0%	Shares	Sole	2026-04-28
2025-12-31	$17,593,854	85,015	-0.8%	Shares	Sole	2026-01-20
2025-09-30	$15,891,235	85,704	-2.4%	Shares	Sole	2025-10-24
2025-06-30	$13,419,545	87,853	+13.5%	Shares	Sole	2025-07-18
2025-03-31	$12,838,503	77,415	+1.7%	Shares	Sole	2025-04-24
2024-12-31	$11,013,969	76,158	-2.2%	Shares	Sole	2025-01-31
2024-09-30	$12,615,074	77,842	+3103.4%	Shares	Sole	2024-10-31
2024-06-30	$355,168	2,430	-12.1%	Shares	Sole	2024-07-23
2024-03-31	$437,078	2,763	-14.0%	Shares	Sole	2024-04-29
2023-12-31	$503,292	3,211	—	Shares	Sole	2024-01-29
No filing history on record for this holder in this stock.